Advertisement

Topics

Is Automation An Elixir For Bringing Spend And Efficiency To Clinical Trials Development Processes?

06:00 EST 8 Jan 2019 | eCliniqua

Clinical Informatics News Contributed Commentary | Automating 50% to 70% of tasks has resulted in annual run-rate cost efficiencies of 25% to 30%, process-time reductions of 50% to 60% and triple-digit returns on investment (ROI) across different industries. Could clinical trials see that sort of return on investment?

Original Article: Is Automation An Elixir For Bringing Spend And Efficiency To Clinical Trials Development Processes?

NEXT ARTICLE

More From BioPortfolio on "Is Automation An Elixir For Bringing Spend And Efficiency To Clinical Trials Development Processes?"

Advertisement
Quick Search
Advertisement
Advertisement

 

Relevant Topic

Clinical Approvals
Clinical trials are a set of procedures in medical research conducted to allow safety (or more specifically, information about adverse drug reactions and adverse effects of other treatments) and efficacy data to be collected for health interventions (e.g...